31 – 40 of 2256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Clinical Implications of Discrepancy between One-stage Clotting and Chromogenic Factor IX Activity in Haemophilia B
(
- Contribution to journal › Article
-
Mark
Molecular coagulation and thrombophilia
2024) p.201-215(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study Nested in a Clinical Trial
(
- Contribution to journal › Article
-
Mark
The future of blood services amid a tight balance between the supply and demand of blood products : Perspectives from the ISBT Young Professional Council
(
- Contribution to journal › Article
-
Mark
Feasibility for non-invasive prenatal fetal blood group and platelet genotyping by massively parallel sequencing : A single test system for multiple atypical red cell, platelet and quality control markers
(
- Contribution to journal › Article
-
Mark
The significance of free light-chain ratio in light-chain monoclonal gammopathy of undetermined significance : a flow cytometry sub-study of the iStopMM screening study
(
- Contribution to journal › Article
-
Mark
Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance : Insights from the iStopMM study
2024) In Blood(
- Contribution to journal › Article
-
Mark
An uncommon MALady : is the AnWj puzzle complete?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Monoclonal gammopathy of undetermined significance and the risk of thrombotic events : Results from iStopMM, a prospective population-based screening study
2024) In British Journal of Haematology(
- Contribution to journal › Article
-
Mark
Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8) : a prospective, multicentre, open-label, randomised, phase 3a trial
(
- Contribution to journal › Article